Pietro Marano

Pietro Marano

Auto-generated profile, based on publicly available information

Pietro Marano

Università di Catania

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
MSMariachiara Sensi
Mariachiara Sensi
GCGiovanni Cossu
Giovanni Cossu
FMFrancesca Mancini
Francesca Mancini
MPManuela Pilleri
Manuela Pilleri
MZMaurizio Zibetti
Maurizio Zibetti
MVMaria Antonietta Volonté
Maria Antonietta Volonté

1 October 2015 in Journal of Rehabilitation Medicine
Verified
Journal Article
Open access
Matteo CioniMatteo Cioni
Matteo Cioni
Oriana AmataOriana Amata
Oriana Amata
MSM Seminara
M Seminara
PMP Marano
P Marano
FPF Palermo
F Palermo
LBLuigia Brugliera
Luigia Brugliera
Journal of Rehabilitation Medicine is an international peer-review journal published in English, with at least 10 issues published per year.

1 May 1992 in The Italian Journal of Neurological Sciences
Verified
Journal Article
Closed access
PDF file
AGA. A. Grasso
A. A. Grasso
ARA. Reggio
A. Reggio
PMP. Marano
P. Marano
SFS. Florio
S. Florio
NSN. Scordino
N. Scordino
FNF. Nicoletti
F. Nicoletti

1 January 1985 in European Neurology
Verified
Journal Article
Closed access
PDF file
FPF. Patti
F. Patti
PMP. Marano
P. Marano
GGG. Giammona
G. Giammona
FNFr. Nicoletti
Fr. Nicoletti
We report that repeated administration of salmon calcitonin (20–40 µg daily for 30 days) improves dystonic symptoms in patients affected by idiopathic torsion dystonia, blepharospasm-oromandibular dystonia syndrome or writer’s cramp syndrome. These results support the suggestion that calcitonin may act at central level influencing the extrapyramidal motor system.

1 October 1986 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
FPFrancesco Patti
Francesco Patti
Filippo DragoFilippo Drago
Filippo Drago
PMPietro Marano
Pietro Marano
FNFrancesco Nicoletti
Francesco Nicoletti
USUmberto Scapagnini
Umberto Scapagnini
A total of 410 patients (342 men and 68 women) addicted to heroin for at least 38 months, with or without previous methadone treatment experience, were treated with sulpiride before the appearance of withdrawal syndrome. The drug was injected intramuscularly in a single administration at a dosage of 600 mg. Successively, sulpiride was injected intramuscularly at a dosage of 200 mg 3 times per day from days 2-21 of hospitalization, and then at a dosage of 100 and 50 mg 3 times per day (days 22-25 and 26-29, respectively). All patients showed a suppression of withdrawal signs and symptoms within 6 days of treatment, as assessed by subjective and objective scores. The effect of sulpiride was compared with that of placebo administered to a control group of 10 heroin addicts. Because prolactin has been shown to reduce the dependence of rats to heroin and the naloxone-precipitated withdrawal syndrome in morphine-addicted animals, the effects of sulpiride on heroin addiction may be related to the hyperprolactinemic action of this drug.

1 January 1988 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
PMPietro Marano
Pietro Marano
FPFrancesco Patti
Francesco Patti
FNFrancesco Nicoletti
Francesco Nicoletti
A double-blind, parallel group study was carried out in 50 patients with an anxiety disorder to compare the anxiolytic efficacy and tolerability of a recently developed benzodiazepine, metaclazepam, with that of bromazepam. Patients were allocated at random to receive treatment for 2 weeks with either 15 mg metaclazepam or 4 mg bromazepam per day in two divided doses. Assessments were made using the Hamilton anxiety rating scale (physician) on entry and after 7 and 13-days' treatment, and a visual analogue scale (patients) on entry and at the end of the study. The results showed that there was a significant, marked reduction in anxiety rating scores after 1 and 2 weeks in both groups and a significant improvement in the patients' subjective assessment of their condition after treatment. Few side-effects were reported in either group.